Alert

Recommended Alerts

Sign Up For Alerts

CMS Finalizes Repeal of Medicare “Breakthrough” Device Coverage Rule, Pledges to Invite Further Industry Input

On November 15, 2021, the Centers for Medicare and Medicaid Services (“CMS”) issued a final rule implementing, without substantial modification, its September proposed rule to repeal the prior administration’s Medicare Coverage of Innovative Technology final rule (the “Repealed MCIT rule”). The repeal will be effective as of December 15, 2021, the same day the Repealed MCIT rule was supposed to have taken effect.

Read More

CMS Aims to Clarify Medicare Policy on Clinical Trial Coverage


Time to Read: 1 minutes Practices: Health Care, Life Sciences Industries: Biotechnology & Pharmaceuticals

Printer-Friendly Version

The Centers for Medicare & Medicaid Services has recently launched a number of initiatives addressing Medicare coverage of clinical trial services, including an upcoming "Question & Answer" document on coverage of clinical trial services; proposed revisions to the national coverage decision on clinical trial services; and a revised guidance document for certain national coverage decisions. To learn more about these significant CMS initiatives, click "Download PDF."

Printer-Friendly Version

Cookie Settings